Azzad Asset Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-4,286
| Closed | -$840K | – | 360 |
|
|
2026
Q1 | $840K | Buy |
4,286
+14
| +0.3% | +$2.72K | 0.08% | 245 |
|
|
2025
Q4 | $741K | Sell |
4,272
-6
| -0.1% | -$1.09K | 0.07% | 273 |
|
|
2025
Q3 | $815K | Buy |
4,278
+274
| +7% | +$48.6K | 0.08% | 259 |
|
|
2025
Q2 | $719K | Buy |
4,004
+82
| +2% | +$14.2K | 0.08% | 252 |
|
|
2025
Q1 | $664K | Buy |
3,922
+66
| +2% | +$10.8K | 0.08% | 252 |
|
|
2024
Q4 | $582K | Buy |
3,856
+65
| +2% | +$10.1K | 0.11% | 145 |
|
|
2024
Q3 | $589K | Buy |
3,791
+111
| +3% | +$16.6K | 0.07% | 264 |
|
|
2024
Q2 | $504K | Buy |
3,680
+141
| +4% | +$19.3K | 0.06% | 264 |
|
|
2024
Q1 | $471K | Buy |
3,539
+46
| +1% | +$5.97K | 0.05% | 273 |
|
|
2023
Q4 | $482K | Buy |
3,493
+95
| +3% | +$12.5K | 0.06% | 268 |
|
|
2023
Q3 | $414K | Buy |
3,398
+184
| +6% | +$24.5K | 0.06% | 273 |
|
|
2023
Q2 | $452K | Buy |
3,214
+33
| +1% | +$4.55K | 0.06% | 283 |
|
|
2023
Q1 | $450K | Buy |
3,181
+17
| +0.5% | +$2.43K | 0.06% | 274 |
|
|
2022
Q4 | $495K | Sell |
3,164
-4,666
| -60% | -$671K | 0.08% | 268 |
|
|
2022
Q3 | $920K | Buy |
7,830
+23
| +0.3% | +$3.03K | 0.09% | 288 |
|
|
2022
Q2 | $949K | Buy |
7,807
+4,754
| +156% | +$648K | 0.09% | 282 |
|
|
2022
Q1 | $418K | Sell |
3,053
-272
| -8% | -$37.9K | 0.06% | 281 |
|
|
2021
Q4 | $575K | Sell |
3,325
-581
| -15% | -$88.4K | 0.08% | 283 |
|
|
2021
Q3 | $568K | Buy |
3,906
+36
| +0.9% | +$5.27K | 0.08% | 282 |
|
|
2021
Q2 | $511K | Buy |
3,870
+49
| +1% | +$6.42K | 0.08% | 283 |
|
|
2021
Q1 | $490K | Buy |
3,821
+148
| +4% | +$18.2K | 0.08% | 276 |
|
|
2020
Q4 | $438K | Buy |
3,673
+95
| +3% | +$11.6K | 0.08% | 258 |
|
|
2020
Q3 | $410K | Sell |
3,578
-1,120
| -24% | -$132K | 0.08% | 257 |
|
|
2020
Q2 | $535K | Buy |
4,698
+1
| +0% | +$106 | 0.13% | 231 |
|
|
2020
Q1 | $377K | Sell |
4,697
-4,635
| -50% | -$480K | 0.11% | 253 |
|
|
2019
Q4 | $1.03M | Sell |
9,332
-953
| -9% | -$99.4K | 0.12% | 239 |
|
|
2019
Q3 | $1.13M | Buy |
10,285
+4,702
| +84% | +$483K | 0.14% | 224 |
|
|
2019
Q2 | $568K | Buy |
5,583
+651
| +13% | +$62.6K | 0.16% | 215 |
|
|
2019
Q1 | $443K | Buy |
+4,932
| New | +$427K | 0.13% | 235 |
|
Other funds holding DGX
EIG
Azzad Asset Management's DGX Position: Q2 2026 in Review
Azzad Asset Management sold out of Quest Diagnostics (DGX) in Q2 2026, closing a stake of 4,286 shares — an estimated $840K sold.
Azzad Asset Management first reported a position in DGX in Q1 2019 and held it in 29 quarters. The position peaked at $1.13M in Q3 2019. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Azzad Asset Management reported no remaining Quest Diagnostics position as of Q2 2026 after selling out during the quarter.
- Azzad Asset Management sold 4,286 Quest Diagnostics shares in Q2 2026, an estimated $840K.
- Azzad Asset Management first reported a position in Quest Diagnostics in Q1 2019 and held it in 29 quarters.
- Azzad Asset Management's Quest Diagnostics position peaked at $1.13M in Q3 2019.
- 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Azzad Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.